The COVID-19 pandemic has introduced unprecedented challenges for pharmaceutical and biotechnology leaders, as your organizations rapidly pivot to develop lifesaving products while preserving day-to-day business operations. We are grateful for the efforts you and your organizations are spearheading during this critical time.
Below you’ll find a collection of educational resources to help you address the most pressing challenges life sciences organizations are facing as a result of COVID-19. We encourage you to connect with us if you need immediate assistance.
Digital Risk Minimization
COVID-19: The Importance of Digital Additional Risk Minimization for Life Sciences Organizations
Client Alert: FDA Issues Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Pandemic